Claudio Reck Rivera

Claudio Reck Rivera is a professional with a diverse background in research, business development, and leadership. Experience includes a role as a Research Assistant at Beth Israel Deaconess Medical Center, where CRISPR-Cas9 was engineered to study the CDKAL1 gene's relation to Type-2 Diabetes. Currently serving as a Business Development Representative at Bioz, prior experience includes an Analyst position at Health Advances, leading a market study on schizophrenia treatments, and a Clinical Research Coordinator role at UCSF Memory and Aging Center, managing a cognitive assessment tool project. Notable leadership positions include serving as President of the Harvard Woodbridge International Students Society and directing speaker outreach for the Latinos in Health Careers Health Conference. Academic credentials include an A.B. in Molecular and Cellular Biology from Harvard University, complemented by language studies in Japanese.